Your session is about to expire
← Back to Search
Soft Bifocal Contact Lens
Soft Bifocal Contact Lenses for Near-sightedness (BLINK2 Trial)
N/A
Waitlist Available
Led By Jeffrey J Walline, OD PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants in the BLINK Study
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two years
Awards & highlights
BLINK2 Trial Summary
This trial is investigating if soft bifocal contact lenses can help slow myopia progression.
Who is the study for?
This trial is for individuals who were part of the BLINK Study, focusing on those with near-sightedness (myopia). It aims to identify biological factors that could predict which patients will benefit most from myopia control using soft bifocal contact lenses.Check my eligibility
What is being tested?
The study tests if wearing soft bifocal contact lenses can slow down the worsening of near-sightedness. The research hinges on earlier findings; if prior results show a 30% improvement, this trial will explore additional benefits and mechanisms.See study design
What are the potential side effects?
While specific side effects are not detailed here, typical concerns with contact lens use include eye discomfort, dry eyes, redness, and potential infection. These aspects may be monitored as part of the study's safety measures.
BLINK2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBLINK2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ two years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The statistical correlation between Light levels and axial length
The statistical correlation between choroidal thickness and axial length
The statistical correlation between iPRGC activity and axial length
Secondary outcome measures
Accommodative amplitude
Accommodative facility
Lag of accommodation
+2 moreBLINK2 Trial Design
1Treatment groups
Experimental Treatment
Group I: Contact lensExperimental Treatment1 Intervention
Depending upon the study lens proven to be the most effective in the BLINK Study, this contact lens will be used for the first two years of the study. The last year of the study, all subjects will be wearing single vision contact lenses.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contact lenses
2009
N/A
~1210
Find a Location
Who is running the clinical trial?
Ohio State UniversityLead Sponsor
837 Previous Clinical Trials
507,698 Total Patients Enrolled
University of HoustonOTHER
148 Previous Clinical Trials
47,350 Total Patients Enrolled
Jeffrey J Walline, OD PhDPrincipal InvestigatorThe Ohio State University College of Optometry
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Contact lens
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Popular Categories
Share this study with friends
Copy Link
Messenger